Michelle Farland, Pharm.D., BCPS, CDE

Michelle Farland

Clinical Associate Professor, Director of Personal and Professional Development Curriculum

Pharmacotherapy and Translational Research


EMAIL: mfarland@cop.ufl.edu

PHONE: 352-273-6293

CV: Link to CV



  • Pharm.D., University of Pittsburgh
  • PGY1 Pharmacy Practice Residency, Shands Jacksonville Medical Center
  • PGY2 Ambulatory/Primary Care Residency, Virginia Commonwealth University Medical Center


Dr. Farland received her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy in 2005. She completed a pharmacy practice residency at Shands Jacksonville Medical Center (now UF Health at Jacksonville) in Jacksonville, Florida and a specialty residency in Ambulatory care/Primary care at the Virginia Commonwealth University Medical College of Virginia Hospitals in Richmond, Virginia. Dr. Farland joined the faculty of the University of Tennessee Health Science Center College of Pharmacy in 2007 and was promoted to Associate Professor in 2012. She then joined the faculty of the University of Florida in 2015. She currently serves as the Director of Personal and Professional Development Curriculum with educational research focusing on outcomes of team-based learning and personal and professional development. Dr. Farland has been recognized by the American College of Clinical Pharmacy with the 2012 New Educator Award, by the Team Based Learning Collaborative (TBLC) in 2016 as a team-based learning consultant-trainer, and by the American Association of Colleges of Pharmacy (AACP) in 2017 as an Emerging Teaching Scholar.

Dr. Farland currently serves as the president-elect of the Team-Based Learning Collaborative (TBLC), and is a member of the American Association of Colleges of Pharmacy (AACP), American College of Clinical Pharmacy (ACCP), and Phi Lambda Sigma Pharmacy Leadership Society (PLS). Dr. Farland has served as a national speaker in the areas of diabetes, chronic pain management and team-based learning.


  • Team Based Learning Collaborative
  • American Association of Colleges of Pharmacy
  • American College of Clinical Pharmacy


Farland’s research focuses on pharmacist impact on patient outcomes for chronic disease states in outpatient interdisciplinary care settings, and implementation of team-based learning in the professional curriculum.


  • Farland MZ, Barlow PB, Levi Lancaster T, Franks AS. Comparison of answer-until-correct and full-credit assessments in a team-based learning course. Am J Pharm Educ. 2015 Mar 25;79(2):21. doi: 10.5688/ajpe79221. PubMed PMID: 25861102.
  • Keeble DS, Farland MZ, Eaddy J. Glycemic control is an important consideration in diabetes care. Am Fam Physician. 2014 Oct 15;90(8):524-6. PubMed PMID: 25369639.
  • Howard-Thompson A, Farland MZ, Byrd DC, Airee A, Thomas J, Campbell J, Cassidy R, Morgan T, Suda KJ. Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes. Ann Pharmacother. 2013 Nov;47(11):1471-7. PubMed PMID: 24285763.
  • Shoulders BR, Franks AS, Barlow PB, Williams JD, Farland MZ. Impact of pharmacists’ interventions and simvastatin dose restrictions. Ann Pharmacother. 2014 Jan;48(1):54-61. PubMed PMID: 24259645.
  • Franklin BE, Farland MZ, Thomas J, McFarland MS, Ray SM, Byrd DC. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model. Ann Pharmacother. 2013 Dec;47(12):1627-34. PubMed PMID: 24259610.
  • Lee PH, Franks AS, Barlow PB, Farland MZ. Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitus. Diabetes Technol Ther. 2014 Mar;16(3):150-5. PubMed PMID: 24224752.